✦ LIBER ✦

Type and Duration of Exogenous Hormone Use Affects Breast Cancer Histology

✍ Scribed by Hwang, E. Shelley

Book ID: 122592645
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 67 KB
Volume: 19
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(08)80004-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type and Duration of Exogenous Hormone U

Type and Duration of Exogenous Hormone Use Affects Breast Cancer Histology

✍ Anjali S. Kumar; Elizabeth Cureton; Veronica Shim; Theadora Sakata; Dan H. Moore 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 482 KB

Type and Duration of Exogenous Hormone U

Type and Duration of Exogenous Hormone Use Affects Breast Cancer Histology

✍ Linares-Fernández, Beatriz E.; Alfieri, Anna B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Prospective study of exogenous hormone u

Prospective study of exogenous hormone use and breast cancer in seventh-day adventists

✍ Paul K. Mills; W. Lawrence Beeson; Roland L. Phillips; Gary E. Fraser 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

Postmenopausal hormone therapy and risk

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

✍ Laura M. Newcomer; Polly A. Newcomb; John D. Potter; Yutaka Yasui; Amy Trentham- 📂 Article 📅 2003 🏛 Springer Netherlands 🌐 English ⚖ 99 KB

Postmenopausal hormone use and breast ca

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype

✍ Eugenia E. Calle; Heather Spencer Feigelson; Janet S. Hildebrand; Lauren R. Tera 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Oral contraceptive use and risk of breas

Oral contraceptive use and risk of breast cancer by histologic type

✍ Laura M. Newcomer; Polly A. Newcomb; Amy Trentham-Dietz; Matthew P. Longnecker; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 62 KB 👁 1 views

We examined the association between oral contraceptive use and risk of specific breast cancer histopathologies in a large, multi-center, population-based, case-control study. Women younger than age 75 with a new diagnosis of invasive breast cancer were identified from 4 statewide tumor registries. W